TwinBeech Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

TwinBeech Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,909	Closed	-$52K	–	795
2022 Q3	$52K	Buy	12,909 +173	+1%	+$1.31K	﹤0.01%	588
2022 Q2	$144K	Buy	+12,736	New	+$153K	0.01%	478
2022 Q1	–	Sell	-6,645	Closed	-$315K	–	613
2021 Q4	$315K	Buy	+6,645	New	+$399K	0.02%	481

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TwinBeech Capital's NBP Position: Q4 2022 in Review

TwinBeech Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 12,909 shares — an estimated $52K sold.

TwinBeech Capital first reported a position in NBP in Q4 2021 and held it in 3 quarters. The position peaked at $315K in Q4 2021. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

TwinBeech Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
TwinBeech Capital sold 12,909 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $52K.
TwinBeech Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 3 quarters.
TwinBeech Capital's NovaBridge Biosciences American Depositary Shares position peaked at $315K in Q4 2021.
69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on TwinBeech Capital's 13F filing for Q4 2022, filed 14 Feb 2023.